Elsevier

Surgical Oncology

Volume 20, Issue 2, June 2011, Pages 121-125
Surgical Oncology

Review
Frantz's tumor: Is mutilating surgery always justified in young patients?

https://doi.org/10.1016/j.suronc.2009.12.003Get rights and content

Abstract

Background

Solid pseudopapillary tumor (Frantz's tumor) of the pancreas is a rare lesion.

It is of low-grade malignancy but can cause extensive local invasion.

The aim of this study was to assess the outcome of Frantz's tumors after incomplete resection.

Methods

We contacted all authors who published case reports describing incomplete resection of Frantz's tumor between 1985 and 2008 to request follow-up information.

Results

Follow-up information was obtained for 11 out 18 patients who underwent incomplete resection.

Estimated median survival rate was 5.7 years (69.5 months).

Conclusion

Since Frantz's tumor typically develops mainly in children and young women, a 5.7 year survival rate is unacceptable. Thus complete resection of locally invasive solid-pseudopapillary tumor of the pancreas is always justified, even at the price of difficult, mutilating surgery.

Introduction

Solid pseudopapillary tumor of the pancreas (Frantz's tumor) is a rare lesion.

It is of low malignant potential, but can produce extensive local invasion.

The best treatment is a complete resection without breaking up the lesion and avoiding laparoscopic approach [1].

However, since the doubling time of this tumor appears to be slow (765 days) [2], the question arises as to whether mutilating resection sacrificing organs and/or blood vessels is warranted.

We decided to assess this question after observing high postoperative morbidity following treatment of a young girl in our department.

The purpose of this report is to describe our patient and a retrospective review of previous cases of incomplete resection for Frantz's tumor.

In order to evaluate long-term risk of this tumor after incomplete resection, we contacted all authors who published case reports describing incomplete resection of Frantz's tumor between 1985 and 2008 to request follow-up information. Incomplete resection was defined in two categories, i.e., resection microscopically incomplete (R1) and resection macroscopically incomplete (R2).

Section snippets

Methods

An 11-year-old girl was admitted to our hospital for vomiting, jaundice and abdominal mass.

Radiologic examination demonstrated a voluminous mass (12 cm) developing from the pancreas to contiguous organs.

A preoperative biopsy was performed and it was diagnosed as a Frantz's tumor (Fig. 1).

The girl was underwent multiple surgical interventions. Procedures included a cephalic duodeno-pancreatectomy extended to isthmus, partial resection of the superior mesenteric vein, right and transverse

Results

We contacted 14 authors (by email, letter, or fax) who reported cases of Frantz's tumor treated by incomplete resection.

One author described 3 cases, two described 2 cases and the other 11 authors described 1 case each.

The total number of cases was 18 including 10 R1 and 8 R2 resections [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16].

In one case the tumor broke up during resection [13].

Eleven authors responded including 2 who could not access the data, 1 who had lost

Discussion

Because of the indolent nature of Frantz's tumor and high morbidity following aggressive surgery [17], [18], the most appropriate surgical approach is still controversial.

According to this retrospective study, overall median survival after incomplete resection of Frantz's tumor reported in the literature was only 5.7 years.

There was no statistically significant difference between patients who underwent R1 resection (microscopically incomplete) or R2 resection (macroscopically incomplete). These

Conclusion

Despite the low malignant potential of Frantz's tumor, the results of our review of the literature show that, median survival in patients who undergo incomplete is only 5.7 years. This is unacceptable for young patients.

Complete surgical resection should be performed in patients presenting locally invasive solid-pseudopapillary tumor of the pancreas, even if it requires difficult, mutilating surgery.

Further study is needed.

Conflict of interest statement

None declared.

Acknowledgments

THANKS TO: M Brennan [13], J Cameron [16], F Carboni [4], K Horvath [6], T Nakagohri [10], LLPJ Ooi [5], J Podevin [12], LM Sclafani [13], M Siech [18], GB Thompson [15] for providing their follow-up data.

References (34)

  • B.K.P. Goh et al.

    Solid pseudopapillary neoplasm of the pancreas: an updated experience

    J Surg Oncol

    (2007)
  • L.B.B. Jeng et al.

    Solid and papillary neoplasm of the pancreas. Emphasis on surgical treatment

    Arch Surg

    (1993)
  • R.C.G. Martin et al.

    Solid-pseudopapillary tumor of the pancreas: a surgical enigma?

    Ann Surg Oncol

    (2002)
  • H. Matsunou et al.

    Papillary cystic neoplasm of the pancreas. A clinicopathologic study concerning the tumor aging and malignancy of nine cases

    Cancer

    (1990)
  • T. Nakagohri et al.

    Surgical outcome of solidpseudopapillary tumor of the pancreas

    J Hepatobil Pancreat Surg

    (2008)
  • K. Nishihara et al.

    Papillary cystic tumors of the pancreas

    Cancer

    (1993)
  • L.M. Sclafani et al.

    The malignant nature of papillary and cystic neoplasm of the pancreas

    Cancer

    (1991)
  • Cited by (32)

    • Frantz tumor in a 58 year old woman; case report and literature review

      2021, Annals of Medicine and Surgery
      Citation Excerpt :

      In general, they are the most useful studies, however, magnetic resonance imaging is very useful to identify chemical and solid tumors in the pancreas, in T1 areas of hemorrhagic degeneration can be determined as well as a hypointense capsule [1,3]. Positron emission tomography in general is not very useful since it is not possible to determine whether it is a benign or malignant neoplasm [4,13,14]. In the case of our patient, based on the findings of the tomography, we decided to take the patient to surgery.

    • Solid pseudo papillary tumor of the pancreas in a 7-year-old girl

      2021, Journal of Pediatric Surgery Case Reports
    • Solid pseudopapillary neoplasm of the pancreas

      2018, Journal of Pediatric Surgery Case Reports
    • Pancreaticoduodenectomy for pediatric and adolescent pancreatic malignancy: A single-center retrospective analysis

      2017, Journal of Pediatric Surgery
      Citation Excerpt :

      Consequently, we concluded that there was no apparent adverse effect on survival among patients who underwent PD for resection of recurrent disease. Pancreaticoduodenectomy is an exceedingly rare procedure in the pediatric population [3,8,14]. We present our series of 12 patients who underwent PD at our institution over the last 21 years.

    • Solid pseudopapillary neoplasm–Case report of a rare pancreatic tumor

      2017, International Journal of Surgery Case Reports
      Citation Excerpt :

      Biopsy and fine needle aspiration cytology are controversial and rarely performed [8]. Described as low malignant potential tumor, surgery is usually indicated with an improved prognosis and overall survival rate of more than 95% [9,12]. Radical resection is commonly performed, namely a pancreatoduodenectomy for pancreatic head tumor and a distal pancreatectomy with or without splenectomy for pancreatic body or tail tumor.

    View all citing articles on Scopus
    View full text